Torbjørn Wisløff

• Vázquez Fernández, Liliana; Diz-Lois Palomares, Alfonso; Vicedo Cabrera, Ana M.; De Blasio, Birgitte Freiesleben; Di Ruscio, Francesco & Wisløff, Torbjørn [Vis alle 7 forfattere av denne artikkelen] (2024). Short-term association between air temperature and mortality in seven cities in Norway: A time series analysis. Scandinavian Journal of Public Health. ISSN 1403-4948. doi: 10.1177/14034948241233359.
• Mecinaj, Albulena; Gulati, Geeta; Ree, Anne Hansen; Gravdehaug, Berit; Røsjø, Helge Rørvik & Steine, Kjetil [Vis alle 10 forfattere av denne artikkelen] (2024). Impact of the ESC Cardio-Oncology Guidelines Biomarker Criteria on Incidence of Cancer Therapy–Related Cardiac Dysfunction. JACC: CardioOncology. ISSN 2666-0873. 6(1), s. 83–95. doi: 10.1016/j.jaccao.2023.10.008.
• Bøhn, Skh; Oldervoll, Line Merethe; Reinertsen, Kristin Valborg; Selland, Mette; Fosså, Alexander & Kiserud, Cecilie E. [Vis alle 17 forfattere av denne artikkelen] (2024). The feasibility of a multidimensional intervention in lymphoma survivors with chronic fatigue. Supportive Care in Cancer. ISSN 0941-4355. 32(1). doi: 10.1007/s00520-023-08204-5.
• Zahl-Holmstad, Birgitte; Garcia, Beate Hennie; Svendsen, Kristian; Johnsgård, Tine; Vesela, Renata & Ofstad, Eirik Hugaas [Vis alle 11 forfattere av denne artikkelen] (2023). Completeness of medication information in admission notes from emergency departments. BMC Health Services Research. ISSN 1472-6963. 23(1). doi: 10.1186/s12913-023-10371-4. Fulltekst i vitenarkiv
• Nystad, Wenche; Hjellvik, Vidar; Larsen, Inger Kristin; Robsahm, Trude Eid; Sund, Erik Reidar & Krokstad, Steinar [Vis alle 18 forfattere av denne artikkelen] (2023). National health registries – a ‘goldmine’ for studying non-communicable disease occurrence in Norway – the NCDNOR project. Scandinavian Journal of Public Health. ISSN 1403-4948. doi: 10.1177/14034948231214580. Fulltekst i vitenarkiv
• Ibarra Sanchez, Ana Silvia; Abelsen, Birgit; Chen, Gang & Wisløff, Torbjørn (2023). Educational patterns of health behaviors and body mass index: A longitudinal multiple correspondence analysis of a middle-aged general population, 2007-2016. PLOS ONE. ISSN 1932-6203. 18(12). doi: 10.1371/journal.pone.0295302. Fulltekst i vitenarkiv
• Andreasen, Camilla; Dahl, Cecilie; Solberg, Lene Bergendal; Borgen, Tove Tveitan; Wisløff, Torbjørn & Gjertsen, Jan-Erik [Vis alle 13 forfattere av denne artikkelen] (2023). Epidemiology of forearm fractures in women and men in Norway 2008–2019. Osteoporosis International. ISSN 0937-941X. doi: 10.1007/s00198-023-06990-6. Fulltekst i vitenarkiv
• Young, Juliet; Seeberg, Kathrine; Aakre, Kristin Moberg; Borgeraas, Heidi; Nordstrand, Njord & Wisløff, Torbjørn [Vis alle 9 forfattere av denne artikkelen] (2023). The liver-heart axis in patients with severe obesity: The association between liver fibrosis and chronic myocardial injury may be explained by shared risk factors of cardiovascular disease. Clinical Biochemistry. ISSN 0009-9120. 123. doi: 10.1016/j.clinbiochem.2023.110688. Fulltekst i vitenarkiv Vis sammendrag

  Background: Severe obesity is associated with increased risk of non-alcoholic fatty liver disease and cardiovascular disease. We hypothesized that liver fibrosis as quantified by the Enhanced Liver Fibrosis (ELF) test would be predictive of myocardial injury and fibrosis, expressed by high sensitivity cardiac troponin T and I (hs-cTnT and hs-cTnI) concentrations. Material and methods: We performed cross-sectional analyses of baseline data from 136 patients (mean age 45 years, 38 % male) with severe obesity participating in the non-randomized clinical trial Prevention of Coronary Heart Disease in Morbidly Obese Patients (ClinicalTrials.gov NCT00626964). Associations between ELF scores, hs-cTnT, and hs-cTnI concentrations were assessed using linear regression analysis. Results: ELF scores were associated with hs-cTnT in the unadjusted model (B 0.381, 95% Confidence Interval [CI] 0.247, 0.514), but the association was attenuated upon adjustment for potential confounders (B -0.031, 95% CI -0.155, 0.093). Similarly, for hs-cTnI, an observed association with ELF scores in the unadjusted model was attenuated upon adjustment for potential confounders ((B 0.432, 95% CI 0.179, 0.685) and (B 0.069, 95% CI -0.230, 0.367), respectively). Age, sex, hypertension, and estimated glomerular filtration rate were amongst the shared predictors of ELF score, hs-cTnT, and hs-cTnI that provided the univariable models with the highest R-squared and lowest Akaike Information Criterion values. Conclusions: Contrary to our hypothesis, ELF score did not predict myocardial injury and fibrosis, but rather demonstrated that an association between liver fibrosis and myocardial injury and fibrosis may be explained by shared risk factors of cardiovascular disease. Keywords: Enhanced Liver Fibrosis test; NT-proBNP; cardiac fibrosis; cardiac troponin; liver fibrosis; myocardial injury; severe obesity.

• Omsland, Tone Kristin; Solberg, Lene Bergendal; Bjørnerem, Åshild Marit; Borgen, Tove Tveitan; Andreasen, Camilla & Wisløff, Torbjørn [Vis alle 23 forfattere av denne artikkelen] (2023). Validation of forearm fracture diagnoses in administrative patient registers. Archives of Osteoporosis. ISSN 1862-3522. 18, s. 1–9. doi: 10.1007/s11657-023-01322-x. Fulltekst i vitenarkiv
• Gjerset, Gunhild Maria; Kiserud, Cecilie E.; Wisløff, Torbjørn; McCarthy, Jane B. & Thorsen, Lene (2023). Perceived burden and need for support among caregivers of cancer patients. Acta Oncologica. ISSN 0284-186X. 62(7), s. 794–802. doi: 10.1080/0284186X.2023.2240008.
• Ibarra Sanchez, Ana Silvia; Chen, Gang & Wisløff, Torbjørn (2023). Are relative educational inequalities in multiple health behaviors widening? A longitudinal study of middle-aged adults in Northern Norway. Frontiers in Public Health. ISSN 2296-2565. 11. doi: 10.3389/fpubh.2023.1190087. Fulltekst i vitenarkiv
• Vervaart, Mathyn Adrianus Marinus; Aas, Eline; Claxton, Karl; Strong, Mark; Welton, Nicky J. & Wisløff, Torbjørn [Vis alle 7 forfattere av denne artikkelen] (2023). General-Purpose Methods for Simulating Survival Data for Expected Value of Sample Information Calculations. Medical decision making. ISSN 0272-989X. 43(5), s. 595–609. doi: 10.1177/0272989X231162069. Fulltekst i vitenarkiv
• Vo, Chi Quynh; Samuelsen, Per-Jostein; Sommerseth, Hilde Leikny; Wisløff, Torbjørn; Wilsgaard, Tom & Eggen, Anne Elise (2023). Comparing the sociodemographic characteristics of participants and non-participants in the population-based Tromsø Study. BMC Public Health. ISSN 1471-2458. 23(1). doi: 10.1186/s12889-023-15928-w. Fulltekst i vitenarkiv
• Johansen, Merethe Lia; Eriksrud, Ola; Thorkildsen, Joachim; Norum, Ole-Jacob Anderssen; Wisløff, Torbjørn & Taksdal, Ingeborg [Vis alle 7 forfattere av denne artikkelen] (2023). Muscle strength characteristics following megaprosthetic knee reconstruction for bone sarcoma. Surgial oncology. ISSN 0960-7404. 48. doi: 10.1016/j.suronc.2023.101944. Fulltekst i vitenarkiv Vis sammendrag

  Objective: To assess muscle strength characteristics in patients with resection and megaprosthetic reconstruction of the knee for bone sarcoma compared to age- and sex-matched controls. Methods: This was a cross-sectional, case-control study. Muscle strength characteristics for knee extension and -flexion were assessed isokinetically at three different joint velocities: 60, 120 and 180°/s, and by the rate of force development (RDFmax) in knee extension. The Toronto Extremity Salvage Score (TESS) was used in patients. Results: Eighteen patients (91.6 months postop.) and 18 controls were included. Relative to controls, patients generated maximal torques of 19%, 23% and 23% in knee extension at 60, 120 and 180°/s, respectively. For knee flexion, patients generated maximal torques of 58%, 53% and 60% at 60, 120, and 180°/s, relative to the controls. RDFmax of the operated leg was 2.75 ± 2.13 N/ms, 7.16 ± 4.78 N/ms for the non-operated leg, and 7.95 ± 4.29 N/ms for the controls. The mean TESS score was 84.0. Conclusion: Patients reached approximately 20% of the maximal knee extension torque. In isometric assessments, they used double the amount of time to generate one-third of the maximal force compared to the controls despite good TESS scores.

• Johannessen, Tonje Rambøll; Halvorsen, Sigrun; Atar, Dan; Munkhaugen, John; Nore, Anne Kathrine & Wisløff, Torbjørn [Vis alle 7 forfattere av denne artikkelen] (2022). Cost-effectiveness of a rule-out algorithm of acute myocardial infarction in low-risk patients: emergency primary care versus hospital setting. BMC Health Services Research. ISSN 1472-6963. 22(1). doi: 10.1186/s12913-022-08697-6. Fulltekst i vitenarkiv Vis sammendrag

  Aims: Hospital admissions of patients with chest pain considered as low risk for acute coronary syndrome contribute to increased costs and crowding in the emergency departments. This study aims to estimate the cost-effectiveness of assessing these patients in a primary care emergency setting, using the European Society of Cardiology (ESC) 0/1-h algorithm for high-sensitivity cardiac troponin T, compared to routine hospital management. Methods: A cost-effectiveness analysis was conducted. For the primary care estimates, costs and health care expenditure from the observational OUT-ACS (One-hoUr Troponin in a low-prevalence population of Acute Coronary Syndrome) study were compared with anonymous extracted administrative data on low-risk patients at a large general hospital in Norway. Patients discharged home after the hs-cTnT assessment were defined as low risk in the primary care cohort. In the hospital setting, the low-risk group comprised patients discharged with a non-specific chest pain diagnosis (ICD-10 codes R07.4 and Z03.5). Loss of health related to a potential increase in acute myocardial infarctions the following 30-days was estimated. The primary outcome measure was the costs per quality-adjusted life year (QALY) of applying the ESC 0/1-h algorithm in primary care. The secondary outcomes were health care costs and length of stay in the two settings. Results: Differences in costs comprise personnel and laboratory costs of applying the algorithm at primary care level (€192) and expenses related to ambulance transports and complete hospital costs for low-risk patients admitted to hospital (€1986). Additional diagnostic procedures were performed in 31.9% (181/567) of the low-risk hospital cohort. The estimated reduction in health care cost when using the 0/1-h algorithm outside of hospital was €1794 per low-risk patient, with a mean decrease in length of stay of 18.9 h. These numbers result in an average per-person QALY gain of 0.0005. Increased QALY and decreased costs indicate that the primary care approach is clearly cost-effective. Conclusion: Using the ESC 0/1-h algorithm in low-risk patients in emergency primary care appears to be cost-effective compared to standard hospital management, with an extensive reduction in costs and length of stay per patient.

• Li, Xiao; Bilcke, Joke; Vazquez Fernandez, Liliana; Bont, Louis; Willem, Lander & Wisløff, Torbjørn [Vis alle 8 forfattere av denne artikkelen] (2022). Cost-effectiveness of Respiratory Syncytial Virus Disease Prevention Strategies: Maternal Vaccine Versus Seasonal or Year-Round Monoclonal Antibody Program in Norwegian Children. Journal of Infectious Diseases. ISSN 0022-1899. 226, s. S95–S101. doi: 10.1093/infdis/jiac064.
• Sahba, Mehdi; Krog, Anne Helene; Pettersen, Erik Mulder; Wisløff, Torbjørn; Sundhagen, Jon Otto & Kazmi, Syed Sajid Hussain (2022). Quality of Life (QoL) Assessment in the Patients Operated with Either Laparoscopic or an Open Aortobifemoral Bypass for Aortoiliac Occlusive Disease (AIOD): 2 Years Results of a Randomized Controlled Trial. Vascular Health and Risk Management. ISSN 1176-6344. 18, s. 61–71. doi: 10.2147/VHRM.S350836. Fulltekst i vitenarkiv
• Vo, Chi Quynh; Samuelsen, Per-Jostein; Sommerseth, Hilde Leikny; Wisløff, Torbjørn; Wilsgaard, Tom & Eggen, Anne Elise (2022). Validity of self-reported educational level in the Tromsø Study. Scandinavian Journal of Public Health. ISSN 1403-4948. doi: 10.1177/14034948221088004. Fulltekst i vitenarkiv
• Nilsen, Tormod Skogstad; Johansen, Sara Hassing; Thorsen, Lene; Fairman, Ciaran M.; Wisløff, Torbjørn & Raastad, Truls (2022). Does Androgen Deprivation for Prostate Cancer Affect Normal Adaptation to Resistance Exercise? International Journal of Environmental Research and Public Health (IJERPH). ISSN 1661-7827. 19(7). doi: 10.3390/ijerph19073820. Fulltekst i vitenarkiv Vis sammendrag

  Background: Loss of muscle mass and muscle function is a common side effect from androgen deprivation therapy (ADT) for prostate cancer (PCa). Here, we explored effects of heavy-load resistance training (RT) on lean body mass and muscle strength changes reported in randomized controlled trials (RCTs) among PCa patients on ADT and in healthy elderly men (HEM), by comparison of results in separate meta-analysis. Methods: RCTs were identified through databases and reference lists. Results: Seven RCTs in PCa patients (n = 449), and nine in HEM (n = 305) were included. The effects of RT in lean body mass change were similar among PCa patients (Standardized mean difference (SMD): 0.4, 95% CI: 0.2, 0.7) and HEM (SMD: 0.5, 95% CI: 0.2, 0.7). It is noteworthy that the within group changes showed different patterns in PCa patients (intervention: 0.2 kg; control: −0.6 kg) and HEM (intervention: 1.2 kg; control: 0.2 kg). The effects of RT on change in muscle strength (measured as 1 RM) were similar between PCa patients and HEM, both for lower body- (PCa: SMD: 1.9, 95% CI: 1.2, 2.5; HEM: SMD: 2.2, 95% CI: 1.0, 3.4), and for upper body exercises (PCa: SMD: 2.0, 95% CI: 1.3, 2.7; HEM: SMD: 1.9, 95% CI: 1.3, 2.6). Conclusions: The effects of RT on lean body mass and 1 RM were similar in PCa patients on ADT and HEM, but the mechanism for the intervention effect might differ between groups. It seems that RT counteracts loss of lean body mass during ADT in PCa patients, as opposed to increasing lean body mass in HEM.

• Pawaskar, Manjiri; Burgess, Colleen; Pillsbury, Matthew; Wisløff, Torbjørn & Flem, Elmira (2021). Clinical and economic impact of universal varicella vaccination in Norway: A modeling study. PLOS ONE. ISSN 1932-6203. 16(7), s. 1–14. doi: 10.1371/journal.pone.0254080. Fulltekst i vitenarkiv
• Selland, Mette; Skrede, Katrine; Lindemann, Kristina Yvonne Kathe; Skaali, Tone Margrethe Olsbu; Blomhoff, Rune & Bruheim, Kjersti [Vis alle 8 forfattere av denne artikkelen] (2021). Distress, problems and unmet rehabilitation needs after treatment for gynecological cancer. Acta Obstetricia et Gynecologica Scandinavica. ISSN 0001-6349. doi: 10.1111/aogs.14310. Fulltekst i vitenarkiv
• Vervaart, Mathyn Adrianus Marinus; Strong, Mark; Claxton, Karl; Welton, Nicky; Wisløff, Torbjørn & Aas, Eline (2021). An Efficient Method for Computing Expected Value of Sample Information for Survival Data from an Ongoing Trial. Medical decision making. ISSN 0272-989X. doi: 10.1177/0272989X211068019. Fulltekst i vitenarkiv
• Vistad, Ingvild; Skorstad, Mette; Demmelmaier, Ingrid; Småstuen, Milada Cvancarova; Lindemann, Kristina Yvonne Kathe & Wisløff, Torbjørn [Vis alle 8 forfattere av denne artikkelen] (2021). Lifestyle and Empowerment Techniques in Survivorship of Gynaecologic Oncology (LETSGO study): A study protocol for a multicentre longitudinal interventional study using mobile health technology and biobanking. BMJ Open. ISSN 2044-6055. 11(7). doi: 10.1136/bmjopen-2021-050930. Fulltekst i vitenarkiv
• Vesela, Renata; Elenjord, Renate; Lehnbom, Elin; Ofstad, Eirik Hugaas; Johnsgård, Tine & Zahl-Holmstad, Birgitte [Vis alle 14 forfattere av denne artikkelen] (2021). Integrating the clinical pharmacist into the emergency department interdisciplinary team: A study protocol for a multicentre trial applying a non-randomised stepped-wedge study design. BMJ Open. ISSN 2044-6055. 11(11). doi: 10.1136/bmjopen-2021-049645. Fulltekst i vitenarkiv
• Flem, Elmira; Graham, Jonathan; Yi, Zinan; Wisløff, Torbjørn & Johnson, Kelly D. (2021). Cost and health impact analysis of herpes zoster vaccination in Norway. Expert review of pharmacoeconomics & outcomes research. ISSN 1473-7167. doi: 10.1080/14737167.2021.1973893.
• Mandrik, Olena (Lena); Severens, J.L. (Hans); Bardach, Ariel; Ghabri, Salah; Hamel, Candyce & Mathes, Tim [Vis alle 9 forfattere av denne artikkelen] (2021). Critical Appraisal of Systematic Reviews With Costs and Cost-Effectiveness Outcomes: An ISPOR Good Practices Task Force Report. Value in Health. ISSN 1098-3015. 24(4), s. 463–472. doi: 10.1016/j.jval.2021.01.002.
• Hagen, Gunhild & Wisløff, Torbjørn (2021). Registry data for use in health technology assessments in Norway – Opportunities and challenges. Norsk Epidemiologi. ISSN 0803-2491. 29(1-2), s. 19–27. doi: 10.5324/nje.v29i1-2.4042. Fulltekst i vitenarkiv
• Watle, Sara Sofie Viksmoen; Næss, Lisbeth Meyer; Tunheim, Gro; Caugant, Dominique A & Wisløff, Torbjørn (2021). Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine. Human Vaccines & Immunotherapeutics. ISSN 2164-5515. 17(8), s. 2777–2787. doi: 10.1080/21645515.2021.1880209. Fulltekst i vitenarkiv Vis sammendrag

  In Norway, the incidence of invasive meningococcal disease (IMD) is higher among 16–19-year-olds than in the general population. Most IMD cases among teenagers are caused by serogroup Y. Since 2011, one dose of meningococcal ACWY conjugate vaccine (MCV4) has been recommended for teenagers with out- of-pocket payment. The teenagers are usually vaccinated through the school health service at age 18. This study aimed to estimate costs and health gains of introducing MCV4 to Norwegian teenagers through the national immunization program (NIP). A Markov model was used to analyze the cost-effectiveness of universal MCV4 vaccination of either 15-year-olds or 18-years-olds. Occurrences of IMD were simulated from 15 until 23 years of age. Costs were estimated from a healthcare perspective. Sensitivity analyses evaluated the impact of vaccine price, vaccination uptake, IMD incidence and discount rate. Compared to today’s practice of vaccinating 18-year-olds with out-of-pocket payment, introducing MCV4 to 15-year- olds in a NIP-setting, with 90% vaccine uptake and 50% rebate on vaccine price, prevented 3.2 hospita-lizations, 0.20 sequelae and 0.47 deaths among 15–23-year-olds, annually. Total costs were reduced by €30,000 and 9.7 quality-adjusted life-years (QALYs) were gained per birth cohort. The probability of cost- effectiveness was 99.0%, assuming a willingness-to-pay threshold of €86,000/QALY for severe diseases in Norway. Cost-effectiveness was highly dependent on vaccine price. Vaccination of 18-year-olds in a NIP- setting was also cost-effective, but less than NIP-vaccination of 15-year-olds. Introduction of MCV4 to the 15-year-olds in the Norwegian NIP is likely to be cost-effective given a rebate on the vaccine price.

• Bøhn, Synne-Kristin Hoffart; Lie, Hanne Cathrine; Reinertsen, Kristin Valborg; Fosså, Sophie Dorothea; Haugnes, Hege Sagstuen & Kiserud, Cecilie E. [Vis alle 9 forfattere av denne artikkelen] (2020). Lifestyle among long-term survivors of cancers in young adulthood. Supportive Care in Cancer. ISSN 0941-4355. 29(1), s. 289–300. doi: 10.1007/s00520-020-05445-6. Fulltekst i vitenarkiv Vis sammendrag

  Abstract Purpose To investigate lifestyle in a population-based sample of long-term (≥ 5 years since diagnosis) young adult cancer survivors (YACSs), and explore factors associated with not meeting the lifestyle guidelines for physical activity (PA), body mass index (BMI), and smoking. Methods YACSs (n = 3558) diagnosed with breast cancer (BC), colorectal cancer (CRC), non-Hodgkin lymphoma (NHL), acute lymphoblastic leukemia (ALL), or localized malignant melanoma (MM) between the ages of 19 and 39 years and treated between 1985 and 2009 were invited to complete a mailed questionnaire. Survivors of localized MM treated with limited skin surgery served as a reference group for treatment burden. Results In total, 1488 YACSs responded (42%), and 1056 YACSs were evaluable and included in the present study (74% females, average age at survey 49 years, average 15 years since diagnosis). Forty-four percent did not meet PA guidelines, 50% reported BMI ≥ 25 and 20% smoked, with no statistically significant differences across diagnostic groups. Male gender, education ≤ 13 years, comorbidity, lymphedema, pain, chronic fatigue, and depressive symptoms were associated with not meeting single and/or an increasing number of lifestyle guidelines. Conclusion A large proportion of long-term YACSs do not meet the lifestyle guidelines for PA, BMI, and/or smoking. Non-adherence to guidelines is associated with several late effects and/or comorbidities that should be considered when designing lifestyle interventions for YACSs.

• Briggs, Andrew H.; Goldstein, Daniel A.; Kirwin, Erin; Meacock, Rachel; Pandya, Ankur & Vanness, David J. [Vis alle 7 forfattere av denne artikkelen] (2020). Estimating (quality-adjusted) life-year losses associated with deaths: With application to COVID-19. Health Economics. ISSN 1057-9230. doi: 10.1002/hec.4208.
• Thorsen, Lene; Haugnes, Hege Sagstuen; Fosså, Sophie Dorothea; Brydøy, Marianne; Tandstad, Torgrim & Wisløff, Torbjørn [Vis alle 13 forfattere av denne artikkelen] (2020). Thromboembolic events after high-intensity training duringcisplatin-based chemotherapy for testicular cancer: Casereports and review of the literature. International Journal of Cancer. ISSN 0020-7136. 147(11), s. 3189–3198. doi: 10.1002/ijc.33151. Fulltekst i vitenarkiv Vis sammendrag

  The randomized “Testicular cancer and Aerobic and Strength Training trial” (TAST‐trial) aimed to evaluate the effect of high‐intensity interval training (HIIT) on cardiorespiratory fitness during cisplatin‐based chemotherapy (CBCT) for testicular cancer (TC). Here, we report on an unexpected high number of thromboembolic (TE) events among patients randomized to the intervention arm, and on a review of the literature on TE events in TC patients undergoing CBCT. Patients aged 18 to 60 years with a diagnosis of metastatic germ cell TC, planned for 3 to 4 CBCT cycles, were randomized to a 9 to 12 weeks exercise intervention, or to a single lifestyle counseling session. The exercise intervention included two weekly HIIT sessions, each with 2 to 4 intervals of 2 to 4 minutes at 85% to 95% of peak heart rate. The study was prematurely discontinued after inclusion of 19 of the planned 94 patients, with nine patients randomized to the intervention arm and 10 to the control arm. Three patients in the intervention arm developed TE complications; two with pulmonary embolism and one with myocardial infarction. All three patients had clinical stage IIA TC. No TE complications were observed among patients in the control arm. Our observations indicate that high‐intensity aerobic training during CBCT might increase the risk of TE events in TC patients, leading to premature closure of the TAST‐trial.

• Melbye, Hasse; Helgeland, Jon; Karlstad, Øystein; Ariansen, Inger; Langhammer, Arnulf & Wisløff, Torbjørn [Vis alle 8 forfattere av denne artikkelen] (2020). Is the disease burden from COPD in Norway falling off? A study of time trends in three different data sources. The International Journal of Chronic Obstructive Pulmonary Disease. ISSN 1176-9106. 15, s. 323–334. doi: 10.2147/COPD.S235106. Fulltekst i vitenarkiv
• Jelin, Elma; Wisløff, Torbjørn; Jørstad, Øystein Kalsnes; Heiberg, Turid & Moe, Morten Carsten (2019). Patient-reported outcome measures in the management of neovascular age-related macular degeneration: a 1-year prospective study. BMJ Open Ophthalmology. ISSN 2397-3269. 4(1), s. 1–8. doi: 10.1136/bmjophth-2019-000353. Fulltekst i vitenarkiv
• Haugnes, Håvard; Elstrøm, Petter; Kacelnik, Oliver; Jadczak, Urszula Agnieszka; Wisløff, Torbjørn & de Blasio, Birgitte Freiesleben (2019). Financial and Temporal Costs of Patient Isolation in Norwegian Hospitals. Journal of Hospital Infection. ISSN 0195-6701. doi: 10.1016/j.jhin.2019.11.012. Fulltekst i vitenarkiv
• Jelin, Elma; Wisløff, Torbjørn; Moe, Morten Carsten & Heiberg, Turid (2019). Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ 25) in a Norwegian population of patients with neovascular age-related macular degeneration compared to a control population. Health and Quality of Life Outcomes. ISSN 1477-7525. 17(1), s. 1–9. doi: 10.1186/s12955-019-1203-0. Fulltekst i vitenarkiv
• Sahba, Mehdi; Krog, Anne Helene; Pettersen, Erik Mulder; Wisløff, Torbjørn; Rogne, Kjetil Gunmudson & Sundhagen, Jon Otto [Vis alle 7 forfattere av denne artikkelen] (2019). Cost comparison analysis of laparoscopic versus open aortobifemoral bypass surgery: A randomized controlled trial. Open Access Journal of Clinical Trials. ISSN 1179-1519. 11, s. 11–18. doi: 10.2147/OAJCT.S192552. Fulltekst i vitenarkiv
• Wisløff, Torbjørn; Mundal, Liv; Retterstøl, Kjetil; Igland, Jannicke & Kristiansen, Ivar Sønbø (2019). Economic evaluation of lipid lowering with PCSK9 inhibitors in patients with familial hypercholesterolemia: Methodological aspects. Atherosclerosis. ISSN 0021-9150. 287, s. 140–146. doi: 10.1016/j.atherosclerosis.2019.06.900. Fulltekst i vitenarkiv
• Haugnes, Håvard; Flem, Elmira & Wisløff, Torbjørn (2019). Healthcare costs associated with varicella and herpes zoster in Norway. Vaccine. ISSN 0264-410X. 37(29), s. 3779–3784. doi: 10.1016/j.vaccine.2019.05.063. Fulltekst i vitenarkiv
• Gjerset, Gunhild Maria; Kiserud, Cecilie E.; Loge, Jon Håvard; Fosså, Sophie Dorothea; Wisløff, Torbjørn & Gudbergsson, Sævar Berg [Vis alle 8 forfattere av denne artikkelen] (2019). Changes in fatigue, health-related quality of life and physical activity after a one-week educational program for cancer survivors. Acta Oncologica. ISSN 0284-186X. 58(5), s. 682–689. doi: 10.1080/0284186X.2018.1562210. Fulltekst i vitenarkiv
• Evensen, Stig; Wisløff, Torbjørn; Lystad, June Ullevoldsæter; Bull, Helen; Martinsen, Egil Wilhelm & Ueland, Torill [Vis alle 7 forfattere av denne artikkelen] (2019). Exploring the potential cost-effectiveness of a vocational rehabilitation program for individuals with schizophrenia in a high-income welfare society. BMC Psychiatry. ISSN 1471-244X. 19(140), s. 1–10. doi: 10.1186/s12888-019-2130-7. Fulltekst i vitenarkiv
• Bøhn, Synne-Kristin Hoffart; Thorsen, Lene; Kiserud, Cecilie E.; Fosså, Sophie Dorothea; Lie, Hanne Cathrine & Loge, Jon Håvard [Vis alle 9 forfattere av denne artikkelen] (2019). Chronic fatigue and associated factors among long-term survivors of cancers in young adulthood. Acta Oncologica. ISSN 0284-186X. 58(5), s. 753–762. doi: 10.1080/0284186X.2018.1557344. Fulltekst i vitenarkiv Vis sammendrag

  Background: Chronic fatigue (CF) is scarcely explored among young adult cancer survivors (YACSs), and more knowledge is needed to develop targeted interventions for YACSs with CF. The present study aimed to investigate the prevalence of CF and associated factors in YACSs. Also, the change of fatigue with time was explored. Material and methods: The present cross-sectional study is part of a nation-wide population based survey of Norwegian survivors of cancer in childhood, adolescence, and young adulthood (The NOR-CAYACS study).YACSs diagnosed at the age of 19–39 years with breast cancer stage ≤ III (BC), colorectal cancer (CRC), non-Hodgkin lymphoma (NHL), acute lymphoblastic leukemia, or non-metastatic malignant melanoma (MM) were included 5–30 years after diagnosis. Survivors of MM treated with limited surgery were included as a reference group. CF was assessed by the Fatigue Questionnaire. Logistic regression analyses were performed to identify factors associated with CF. Results: In total, 1488 survivors completed the questionnaire (a response rate of 42%), of which 1088 were eligible for the present study. Overall, 25% reported CF. CF was significantly more prevalent among survivors of BC (29%) (p < .001), CRC (29%) (p = .001) and NHL (27%) (p = .003) than among survivors of MM (15%). CF was associated with systemic treatment combined with surgery and/or radiotherapy (p = .018), comorbidity (p = .038), pain (p = .002), numbness in hands/feet (p = .046), and depressive symptoms (p < .001) in the multivariable model. Among survivors with CF, 60% reported that they had been tired since cancer treatment, and among these, 65% reported worsening or no change of fatigue with time. Conclusion: One of four YACSs reported CF 15 years from diagnosis (mean). CF was associated with several possibly treatable factors. Health professionals involved in the follow-up of YACSs should have knowledge of CF and approaches to manage it.

• Andreasen, Camilla; Solberg, Lene Bergendal; Basso, Trude; Borgen, Tove Tveitan; Dahl, Cecilie & Wisløff, Torbjørn [Vis alle 20 forfattere av denne artikkelen] (2018). Effect of a Fracture Liaison Service on the Rate of Subsequent Fracture Among Patients With a Fragility Fracture in the Norwegian Capture the Fracture Initiative (NoFRACT): A Trial Protocol. JAMA Network Open. ISSN 2574-3805. 1(8). doi: 10.1001/jamanetworkopen.2018.5701. Fulltekst i vitenarkiv
• Bøhn, Synne-Kristin Hoffart; Fosså, Sophie Dorothea; Wisløff, Torbjørn & Thorsen, Lene (2018). Physical activity and associations with treatment-induced adverse effects among prostate cancer patients. Supportive Care in Cancer. ISSN 0941-4355. 27(3), s. 1001–1011. doi: 10.1007/s00520-018-4389-5.
• Jelin, Elma; Wisløff, Torbjørn; Moe, Morten Carsten & Heiberg, Turid (2018). Development and testing of a patient-derived questionnaire for treatment of neovascular age-related macular degeneration: dimensions of importance in treatment of neovascular age-related macular degeneration. Acta Ophthalmologica. ISSN 1755-375X. 96(8), s. 804–811. doi: 10.1111/aos.13847.
• Lousdal, Mette Lise; Møller, Mette H.; Kristiansen, Ivar Sønbø; Kalager, Mette; Wisløff, Torbjørn & Støvring, Henrik (2018). The Screening Illustrator: separating the effects of lead-time and overdiagnosis in mammography screening. European Journal of Public Health. ISSN 1101-1262. 28(6), s. 1138–1142. doi: 10.1093/eurpub/cky085.
• Wisløff, Torbjørn; White, Richard Aubrey; Dalgard, Olav; Amundsen, Ellen Johanna; Meijerink, Hinta & Kløvstad, Hilde (2018). Feasibility of reaching world health organization targets for hepatitis C and the cost‐effectiveness of alternative strategies. Journal of Viral Hepatitis. ISSN 1352-0504. 25(9), s. 1066–1077. doi: 10.1111/jvh.12904. Fulltekst i vitenarkiv
• Korman, Max; Retterstøl, Kjetil; Kristiansen, Ivar Sønbø & Wisløff, Torbjørn (2018). Are PCSK9 Inhibitors Cost Effective? PharmacoEconomics (Auckland). ISSN 1170-7690. 36(9), s. 1031–1041. doi: 10.1007/s40273-018-0671-0. Fulltekst i vitenarkiv
• Bleka, Øyvind; Wisløff, Torbjørn; Dahlberg, Pål Skage; Rolseth, Veslemøy & Egeland, Thore (2018). Advancing estimation of chronological age by utilizing available evidence based on two radiographical methods. International journal of legal medicine (Print). ISSN 0937-9827. 133(1), s. 217–229. doi: 10.1007/s00414-018-1848-y. Fulltekst i vitenarkiv
• Mundal, Liv; Igland, Jannicke; Veierød, Marit Bragelien; Holven, Kirsten Bjørklund; Ose, Leiv & Selmer, Randi [Vis alle 11 forfattere av denne artikkelen] (2018). Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia. Heart. ISSN 1355-6037. 104, s. 1600–1607. doi: 10.1136/heartjnl-2017-312706. Fulltekst i vitenarkiv
• Wisløff, Torbjørn; White, Richard Aubrey; Dalgard, Olav; Amundsen, Ellen Johanna; Meijerink, Hinta & Løvlie, Astrid Louise [Vis alle 7 forfattere av denne artikkelen] (2018). Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway. PharmacoEconomics (Auckland). ISSN 1170-7690. 36(5), s. 591–601. doi: 10.1007/s40273-017-0604-3. Fulltekst i vitenarkiv
• Korman, Max & Wisløff, Torbjørn (2018). Modelling the cost-effectiveness of PCSK9 inhibitors vs. ezetimibe through LDL-C reductions in a Norwegian setting. European Heart Journal. ISSN 0195-668X. 4(1), s. 15–22. doi: 10.1093/ehjcvp/pvx010. Fulltekst i vitenarkiv
• Lie, Irene; Danielsen, Stein Ove; Tønnessen, Theis; Solheim, Svein; Leegaard, Marit & Sandvik, Leiv [Vis alle 10 forfattere av denne artikkelen] (2017). Determining the impact of 24/7 phone support on hospital readmissions after aortic valve replacement surgery (the AVRre study): Study protocol for a randomised controlled trial. Trials. ISSN 1745-6215. 18:246, s. 1–9. doi: 10.1186/s13063-017-1971-y.
• Krog, Anne Helene; Sahba, Mehdi; Pettersen, Erik Mulder; Wisløff, Torbjørn; Sundhagen, Jon Otto & Kazmi, Syed Sajid Hussain (2017). Cost-utility analysis comparing laparoscopic vs open aortobifemoral bypass surgery. Vascular Health and Risk Management. ISSN 1176-6344. 13, s. 217–224. doi: 10.2147/VHRM.S138516. Fulltekst i vitenarkiv
• Gjerset, Gunhild Maria; Loge, Jon Håvard; Kiserud, Cecilie E.; Fosså, Sophie Dorothea; Gudbergsson, Sævar Berg & Oldervoll, Line Merethe [Vis alle 8 forfattere av denne artikkelen] (2017). Perceived needs for different components in a rehabilitation program among cancer survivors with chronic fatigue compared to survivors without chronic fatigue. Acta Oncologica. ISSN 0284-186X. 56(2), s. 245–253. doi: 10.1080/0284186X.2016.1266091. Fulltekst i vitenarkiv
• Pike, Eva; Hamidi, Vida; Ringerike, Tove; Wisløff, Torbjørn & Klemp, Marianne (2017). More Use of Peritoneal Dialysis Gives Significant Savings: A Systematic Review and Health Economic Decision Model. Journal of Clinical Medicine Research. ISSN 1918-3003. 9(2), s. 104–116. doi: 10.14740/jocmr2817w. Fulltekst i vitenarkiv
• Werner, Erik Lønnmark; Storheim, Kjersti; Løchting, Ida; Wisløff, Torbjørn & Grotle, Margreth (2016). Cognitive patient education for low back pain in primary care: A cluster randomized controlled trial and cost-effectiveness analysis. Spine. ISSN 0362-2436. 41(6), s. 455–462. doi: 10.1097/BRS.0000000000001268.
• Hagen, Gunhild; Wisløff, Torbjørn & Kristiansen, Ivar Sønbø (2016). The predicted lifetime costs and health consequences of calcium and vitamin D supplementation for fracture prevention—the impact of cardiovascular effects. Osteoporosis International. ISSN 0937-941X. 27(6), s. 2089–2098. doi: 10.1007/s00198-016-3495-9.
• Wisløff, Torbjørn & Atar, Dan (2016). Cost-effectiveness of antiplatelet drugs after percutaneous coronary intervention. European Heart Journal - Quality of Care and Clinical Outcomes. ISSN 2058-5225. 2(1), s. 52–57. doi: 10.1093/ehjqcco/qcv023.
• Evensen, Stig; Wisløff, Torbjørn; Lystad, June Ullevoldsæter; Bull, Helen Christine; Ueland, Toril & Falkum, Erik (2016). Prevalence, employment rate, and cost of schizophrenia in a high-income welfare society: A population-based study using comprehensive health and welfare registers. Schizophrenia Bulletin. ISSN 0586-7614. 42(2), s. 476–483. doi: 10.1093/schbul/sbv141. Vis sammendrag

  Schizophrenia is associated with recurrent hospitalizations, need for long-term community support, poor social functioning, and low employment rates. Despite the wideranging financial and social burdens associated with the illness, there is great uncertainty regarding prevalence, employment rates, and the societal costs of schizophrenia. The current study investigates 12-month prevalence of patients treated for schizophrenia, employment rates, and cost of schizophrenia using a population-based top-down approach. Data were obtained from comprehensive and mandatory health and welfare registers in Norway. We identified a 12-month prevalence of 0.17% for the entire population. The employment rate among working-age individuals was 10.24%. The societal costs for the 12-month period were USD 890 million. The average cost per individual with schizophrenia was USD 106 thousand. Inpatient care and lost productivity due to high unemployment represented 33% and 29%, respectively, of the total costs. The use of mandatory health and welfare registers enabled a unique and informative analysis on true population-based datasets.

• Meyer, Käthe Birgitte; Wahl, Astrid Klopstad; Bjørk, Ida Torunn; Wisløff, Torbjørn; Hartmann, Anders & Andersen, Marit Helen (2016). Long-term, self-reported health outcomes in kidney donors. BMC Nephrology. ISSN 1471-2369. 17(8). doi: 10.1186/s12882-016-0221-y.

Se alle arbeider i Cristin

• Wisløff, Torbjørn (2023). Et helseøkonomisk blikk på oppfølging etter gynekologisk kreftbehandling.
• Andreasen, Camilla; Dahl, Cecilie; Frihagen, Frede ; Borgen, Tove Tveitan; Basso, Trude & Gjertsen, Jan-Erik [Vis alle 20 forfattere av denne artikkelen] (2023). Fracture Liaison Services and Subsequent Fracture Risk: a multicenter, pragmatic, Stepped-Wedge Cluster-Randomized controlled trial.
• Vo, Chi Quynh; Wilsgaard, Tom; Samuelsen, Per-Jostein; Mathiesen, Ellisiv Bøgeberg; Sommerseth, Hilde Leikny & Eggen, Anne Elise [Vis alle 7 forfattere av denne artikkelen] (2023). Longitudinal cholesterol trends across educational groups: the influence of lipid-lowering drugs in the population-based Tromsø Study 1994-2016.
• Thulin, Ingrid Viola Lavesson; Jordalen, Silje Marie Farestveit; Lekven, Ole Christian; Krishnapillai, Jeyaseelan; Steiro, Ole-Thomas & Collinson, Paul [Vis alle 14 forfattere av denne artikkelen] (2023). Aiming toWards Evidence baSed inTerpretation of Cardiac biOmarkers in patients pResenting with chest pain using Point of Care Testing (WESTCOR- POC): study design. Scandinavian Cardiovascular Journal. ISSN 1401-7431. 57(1). doi: 10.1080/14017431.2023.2272585. Fulltekst i vitenarkiv
• Aziz, Asma; Julin, Cathinka H.; Dudman, Susanne Gjeruldsen; Øverbø, Joakim; Ali, Mohammad & Stene-Johansen, Kathrine [Vis alle 13 forfattere av denne artikkelen] (2023). Exposure to Hepatitis E vaccine (Hecolin®) and pregnancy outcome: Preliminary results from a Phase IV effectiveness study in rural Bangladesh.
• Dudman, Susanne Gjeruldsen; Øverbø, Joakim; Aziz, Asma; Julin, Cathinka H.; Stene-Johansen, Kathrine & Qadri, Firdausi [Vis alle 14 forfattere av denne artikkelen] (2023). Immunogenicity after three doses of a recombinant hepatitis E vaccine in female participants in a randomized placebo-controlled trial in rural Bangladesh.
• Nilsen, Tormod Skogstad; Sæter, Mali; Sarvari, Sebastian; Reinertsen, Kristin Valborg; Johansen, Sara Hassing & Edvardsen, Elisabeth Rustad [Vis alle 17 forfattere av denne artikkelen] (2023). Effects of Aerobic Exercise on Cardiorespiratory Fitness, Cardiovascular Risk Factors, and Patient-Reported Outcomes in Long-Term Breast Cancer Survivors: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. ISSN 1929-0748. 12. doi: 10.2196/45244. Fulltekst i vitenarkiv
• Parr, Christine Louise; Nystad, Wenche; Karlstad, Øystein; Øymar, Knut Asbjørn Alexander; Langhammer, Arnulf & Nafstad, Per [Vis alle 7 forfattere av denne artikkelen] (2022). Ten-year trends of national healthcare costs of asthma, allergic rhinitis, and atopic eczema in 3 million Norwegians. Allergy. European Journal of Allergy and Clinical Immunology. ISSN 0105-4538. doi: 10.1111/all.15225.
• Vo, Chi Quynh; Samuelsen, Per-Jostein; Sommerseth, Hilde Leikny; Wisløff, Torbjørn; Wilsgaard, Tom & Eggen, Anne Elise (2021). Validity of self-reported educational level in the Tromsø Study.
• Vervaart, Mathyn Adrianus Marinus; Aas, Eline; Asphaug, Lars; Bjørnelv, Gudrun Maria Waaler; Burger, Emily Annika & Wisløff, Torbjørn (2021). Undervurdering av en kompleks problemstilling. Dagens medisin. ISSN 1501-4290.
• Vervaart, Mathyn Adrianus Marinus; Aas, Eline; Asphaug, Lars; Bjørnelv, Gudrun Maria Waaler; Burger, Emily Annika & Wisløff, Torbjørn (2021). I strid med etablert kunnskap. Dagens medisin. ISSN 1501-4290.
• Johannessen, Tonje Rambøll; Halvorsen, Sigrun; Atar, Dan; Munkhaugen, John; Nore, Anne Kathrine & Wisløff, Torbjørn [Vis alle 7 forfattere av denne artikkelen] (2021). Cost-minimization analysis of acute myocardial infarction rule-out in low-risk patients: emergency primary care versus hospital.
• Johannessen, Tonje Rambøll; Halvorsen, Sigrun; Atar, Dan; Munkhaugen, John; Nore, Anne Kathrine & Wisløff, Torbjørn [Vis alle 7 forfattere av denne artikkelen] (2021). Cost-minimisation analysis of acute myocardial infarction rule-out in low-risk patients: primary care emergency setting versus hospital setting.
• Wisløff, Torbjørn (2020). Nye terskelverdier som følge av COVID-19?
• Wisløff, Torbjørn (2020). Trygt å trene ved treningssentre? Aftenposten (morgenutg. : trykt utg.). ISSN 0804-3116. s. 35–35.
• Danielsen, Anders Skyrud; Wisløff, Torbjørn & Gopinathan, Unni (2020). Usikkert om barn og smitte. Dagbladet. ISSN 0805-3766.
• Wisløff, Torbjørn (2020). Restriksjonene – og dødeligheten. Dagens medisin. ISSN 1501-4290.
• Wisløff, Torbjørn (2019). Samfunnsøkonomiske konsekvenser ved kreft – kreftrehabilitering i lys av dette.
• Wisløff, Torbjørn (2019). Literature Selection and Validation.
• Wisløff, Torbjørn (2019). SMDM Symposium: Value for Whom? Choice and Consequences of Perspective in Economic Evaluations.
• Kunst, Natalia; Grosse, Scott; Chen, Yao-Hsuan; Kim, David & Wisløff, Torbjørn (2019). Overview of various recommendations for health economic perspective. Symposium: Value for whom? Choice and Consequences of Perspective in Economic Evaluations.
• Jelin, Elma; Heiberg, Turid; Moe, Morten Carsten & Wisløff, Torbjørn (2018). Patient Reported Outcome measures in neovascular Age-Related Macular Degeneration.
• Jelin, Elma; Moe, Morten Carsten; Wisløff, Torbjørn & Heiberg, Turid (2018). Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ 25) tested in observational longitudinal study of patients with neovascular Age-related Macular Degeneration (Norwegian cohort).
• Wisløff, Torbjørn (2017). Communication of opportunity cost.
• Jelin, Elma; Heiberg, Turid; Moe, Morten Carsten & Wisløff, Torbjørn (2017). The development and psychometric performance of a new patient derived tool to measure important Dimensions In Treatment of Age-related Macular Degeneration (DITAMD). Acta Ophthalmologica. ISSN 1755-375X.
• Jelin, Elma; Heiberg, Turid; Moe, Morten Carsten & Wisløff, Torbjørn (2017). The development and psychometric performance of a new patient derived tool to measure important Dimensions In Treatment of Age-related Macular Degeneration (DITAMD).
• Lie, Irene; Danielsen, Stein Ove; Tønnessen, Theis; Solheim, Svein; Leegaard, Marit & Sandvik, Leiv [Vis alle 10 forfattere av denne artikkelen] (2017). Determining the impact of 24/7 phone support on hospital readmissions after aortic valve replacement surgery (the AVRre study): study protocol for a randomised controlled trial. Trials. ISSN 1745-6215. 18. doi: 10.1186/s13063-017-1971-y.
• Solberg, Lene Bergendal; Frihagen, Frede; Basso, Trude; Gjesdal, Clara Gram; Eriksen, Erik Fink & Nordsletten, Lars [Vis alle 12 forfattere av denne artikkelen] (2017). Updates on the Norwegian Capture the Fracture® Initiative (NoFRACT).
• Wisløff, Torbjørn (2017). Ny norsk terskelverdi for verdien av et godt leveår? Tidsskrift for Den norske legeforening. ISSN 0029-2001. 137(7/8), s. 518–518. doi: 10.4045/tidsskr.17.0137.
• Wisløff, Torbjørn (2016). Prioritering og HTA i Norge.
• Jelin, Elma; Heiberg, Turid; Moe, Morten Carsten & Wisløff, Torbjørn (2016). Patient Derived tool to measure Dimensions of Treatment in Age-related Macular Degeneration.
• Hagen, Gunhild; Wisløff, Torbjørn & Kristiansen, Ivar Sønbø (2016). Bør Tine rekruttere melkedrikkere? Aftenposten (morgenutg. : trykt utg.). ISSN 0804-3116.
• Mundal, Liv; Igland, Jannicke; Veierød, Marit Bragelien; Holven, Kirsten Bjørklund; Selmer, Randi & Wisløff, Torbjørn [Vis alle 8 forfattere av denne artikkelen] (2016). INCIDENCE OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH GENOTYPED FAMILIAL HYPERCHOLESTEROLEMIA IN NORWAY DURING 2001-2009. Circulation. ISSN 0009-7322. 134 (25), s. E711–E711.
• Jelin, Elma; Heiberg, Turid; Moe, Morten Carsten & Wisløff, Torbjørn (2015). The Development of a new Patient Derived tool to measure Dimensions of Treatment in Age-related Macular Degeneration (DiTAMD).
• Wisløff, Torbjørn & Robberstad, Bjarne (2015). Re: Markov-modellering :. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 135(16). doi: 10.4045/tidsskr.15.0837.
• Wisløff, Torbjørn (2015). Prioriteringskriterier i helsetjenesten :. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 135(15), s. 1373–1375. doi: 10.4045/tidsskr.15.0228.
• Watle, Sara Sofie Viksmoen; Næss, Lisbeth Meyer; Juvet, Lene Kristine; Wisløff, Torbjørn; Tveteraas, Ingun Heiene & Evensen, Gro [Vis alle 7 forfattere av denne artikkelen] (2023). Meningokokkvaksine til ungdom i nasjonalt vaksinasjonsprogram. Folkehelseinstituttet. Område for smittevern. ISSN 978-82-8406-383-6. Fulltekst i vitenarkiv Vis sammendrag

  Innføring av én dose meningokokk ACWY-vaksine til ungdom i barnevaksinasjonsprogrammet gir individuell og samfunnsmessig nytte. Tiltaket er kostnadseffektivt og kostnadsbesparende for helsetjenesten, og vil redusere sosiale ulikheter i helse. • Meningokokk ACWY-vaksine gir høye nivåer av beskyttende antistoffer (serum baktericide antistoffer, SBA) som er effektmålet som benyttes av regulatoriske myndigheter for å vurdere effekt av meningokokkvaksiner. Funnene støttes av studier i land som har innført vaksine i barnevaksinasjonsprogrammet til ungdom som viser at vaksinasjon reduserer forekomst av meningokokksykdom blant vaksinerte. • Meningokokk ACWY-vaksine reduserer bærerskap av meningokokker blant vaksinerte og bidrar til indirekte beskyttelse av ikke-vaksinerte (flokkbeskyttelse). • Meningokokk ACWY-vaksine har en god sikkerhetsprofil. • Tilbud om én dose meningokokk ACWY vaksine til ungdom ved 15- eller 18-års alder i barnevaksinasjonsprogrammet er kostnadseffektivt sammenliknet med hvis vaksine gis ved 18 års alder og betales av ungdommen selv. • Både vaksinasjon av 15-åringer og 18-åringer i program var kostnadsbesparende (dominante) ved 50 % rabatt på vaksine og 90 % vaksinasjonsdekning. Pris og dekningsgrad på vaksine vil kunne påvirke kostnadseffektiviteten. • Vaksinasjon av 15-åringer i program var mer kostnadseffektivt og kostnadsbesparende enn vaksinasjon av 18-åringer i program. • Forekomsten av meningokokksykdom har gått ned i Norge de senere årene blant unge. Likevel dør det en ungdom av meningokokksykdom hvert til hvertannet år og mange overlevende får livsvarige skader. Nedgangen i antall tilfeller skyldes delvis at mange følger anbefalingen om å vaksinere seg. • Det er store geografiske forskjeller i oppslutning om meningokokk ACWY-vaksine blant 18-åringer som delvis skyldes at tilbudet varierer avhengig av hvor i landet du bor og ikke er gratis for alle. Ungdom og helseykepleiere opplever dagens ordning som urettferdig og at det bidrar til at ikke alle unge får muligheten til å beskytte seg mot en svært alvorlig sykdom grunnet sosioøkonomiske forhold.

• Hauge, Siri Helene; Meijerink, Hinta; Alveberg, Benedikte Louise; Berg, Are Stuwitz; Bergh, Anne & Bragstad, Karoline [Vis alle 28 forfattere av denne artikkelen] (2020). Urbanization and preparedness for outbreaks with high-impact respiratory pathogens. Norwegian Institute of Public Health. ISSN 978-82-8406-107-8. Fulltekst i vitenarkiv
• Berg, Are Stuwitz; Furuseth, Ellen; Greve-Isdahl, Margrethe; Grosvold, Ivar Wilhelm; Næss, Lisbeth Meyer & Nøkleby, Hanne Magdalene [Vis alle 12 forfattere av denne artikkelen] (2019). Kikhostevaksine til gravide – aktuelt for Norge? Folkehelseinstituttet. ISSN 978-82-8406-049-1.
• Jimenez, Enrique; Wisløff, Torbjørn & Klemp, Marianne (2014). Cost-effectiveness of a HPV-vaccination catch-up program for females aged 26 years or younger in a Norwegian setting. Norwegian Knowledge Centre for the Health Services. ISSN 978-82-8121-851-2. 2014(5). Fulltekst i vitenarkiv

Se alle arbeider i Cristin